Exane Derivatives Levi Strauss & CO Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Levi Strauss & CO stock. As of the latest transaction made, Exane Derivatives holds 1,826 shares of LEVI stock, worth $31,881. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,826
Previous 9,072
79.87%
Holding current value
$31,881
Previous $179,000
83.8%
% of portfolio
0.02%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding LEVI
# of Institutions
267Shares Held
74.5MCall Options Held
2.28MPut Options Held
1.02M-
Vanguard Group Inc Valley Forge, PA8.69MShares$152 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C37.52MShares$131 Million0.18% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.63MShares$116 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA6.59MShares$115 Million0.03% of portfolio
-
Marshall Wace, LLP London, X03.04MShares$53.1 Million0.09% of portfolio
About LEVI STRAUSS & CO
- Ticker LEVI
- Exchange NYSE
- Sector Consumer Cyclical
- Industry Apparel Manufacturing
- Shares Outstandng 96,787,296
- Market Cap $1.69B
- Description
- Levi Strauss & Co. operates as an apparel company. The company designs, markets, and sells jeans, casual and dress pants, activewear, tops, shorts, skirts, dresses, jackets, footwear, and related accessories for men, women, and children in the Americas, Europe, and Asia. It also sells its products under the Levi's, Dockers, Signature by Levi...